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Abstract: 
The GRAS plant Artemisia annua L. produces the sesquiterpene lactone, artemisinin. The 
current therapy for malaria is artemisinin + an older drug: artemisinin combination therapy 
(ACT). In Plasmodium chabaudi-infected mice, dried leaves of A. annua are more potent than 
equal amounts of pure artemisinin and may also prevent artemisinin drug resistance from 
emerging. This whole plant therapy is pACT: plant-based artemisinin combination therapy. 
Pharmacokinetics in healthy and infected mice given either pure artemisinin or pACT is different 
and showed that > 40 fold more artemisinin enters the blood when plant material is present; 
plant matrix enhanced bioavailability into serum. Dried leaves as capsules or tablets given to 
African malaria patients were also efficacious. Flavonoids, phenolic acids, monoterpenes and 
other artemisinic metabolites found in the plant have mild antimalarial activity. Some may 
synergize with artemisinin to enhance its efficacy. In simulated digestion studies the effects of 
cellulose and gelatin capsules, sucrose, 4 oils, and 3 staple grains (rice, corn, and millet) were 
studied to determine their effect on AN and flavonoid release into the liquid phase of the 
intestinal stage of digestion. Compared to pACT alone: sucrose and oil enhanced release of 
flavonoids by 100%, but artemisinin was unaffected; both capsule types, and corn and millet 
meal significantly reduced artemisinin release, but had no effect on flavonoids. From field trials 
in MA, it was estimated that > 500,000 patients could be treated from plants grown on 1 ac of 
land. Analysis of 10 crops of the high artemisinin-producing WPI clone of A. annua grown under 
different field and lab conditions showed there was consistent production of artemisinin at about 
1.4% DW. Together these results show how a simple herbal remedy could be used as an 
efficacious, inexpensive, controlled and sustainable orally delivered therapeutic for treating 
malaria and other artemisinin-susceptible diseases.  
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